EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Systemic Sclerosis—Recent Advances in Diagnosis and Management

William J Kerrigan iD, Alistair C Church iD, Ariane L Herrick iD

British Journal of Hospital Medicine · 2025

DOI: 10.12968/hmed.2024.0940 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, 2025. Verfasst von William J Kerrigan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, NHS Golden Jubilee, Glasgow, UK. Hauptthemen laut MEDLINE: Scleroderma, Systemic. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis is a multisystem connective tissue disease which can present to a broad range of medical specialities. It carries significant morbidity and mortality, but substantial advances have been made in recent years. Recent advances include autologous haematopoietic stem cell transplantation for early diffuse disease (for highly selected patients), the increasing use of phosphodiesterase type 5 inhibitors and of bosentan for digital ulceration, a better understanding of the use of different immunosuppressant therapies for interstitial lung disease (and which patients are likely to benefit from antifibrotic therapy), and the increasing early use of combination therapies for pulmonary arterial hypertension (PAH). Ongoing clinical trials investigating new therapeutic approaches should lead to further advances in the next 10 years. This review provides a broad overview of the condition with a focus on recent progress in specific areas: early diffuse cutaneous disease, digital vasculopathy, interstitial lung disease, and PAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicHumansLung Diseases, InterstitialHematopoietic Stem Cell TransplantationHypertension, PulmonaryImmunosuppressive AgentsPhosphodiesterase 5 InhibitorsBosentanSulfonamides

Stichwörter der Autor:innen

digital vasculopathyinterstitial lung diseasepulmonary arterial hypertensionpulmonary hypertensionsclerodermasystemic sclerosis

Substanzen

Immunosuppressive AgentsPhosphodiesterase 5 InhibitorsBosentanSulfonamides

Autor:innen und Institutionen

  • Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, NHS Golden Jubilee, Glasgow, UK.
  • School of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow, UK.
  • Centre for Musculoskeletal Research, The University of Manchester, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Rheumatology Department, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.

ORCID-Profile: William J Kerrigan, Alistair C Church, Ariane L Herrick

Zitieren

APA

Kerrigan, W. J., Church, A. C., & Herrick, A. L. (2025). Systemic Sclerosis—Recent Advances in Diagnosis and Management. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2024.0940

Vancouver

Kerrigan WJ, Church AC, Herrick AL. Systemic Sclerosis—Recent Advances in Diagnosis and Management. British Journal of Hospital Medicine. 2025. doi:10.12968/hmed.2024.0940

BibTeX
@article{Kerrigan2025,
  author = {Kerrigan, William J and Church, Alistair C and Herrick, Ariane L},
  title = {Systemic Sclerosis—Recent Advances in Diagnosis and Management},
  journal = {British Journal of Hospital Medicine},
  year = {2025},
  doi = {10.12968/hmed.2024.0940}
}
Kostenlos starten →